Stocks and Investing Stocks and Investing
Mon, February 26, 2024

Gregory Renza Maintained (ADCT) at Buy with Increased Target to $8 on, Feb 26th, 2024


Published on 2024-10-28 09:12:19 - WOPRAI, Gregory Renza
  Print publication without navigation


Gregory Renza of RBC Capital, Maintained "ADC Therapeutics SA" (ADCT) at Buy with Increased Target from $6 to $8 on, Feb 26th, 2024.

Gregory has made no other calls on ADCT in the last 4 months.



There are 2 other peers that have a rating on ADCT. Out of the 2 peers that are also analyzing ADCT, 1 agrees with Gregory's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Boris Peaker of "TD Cowen" Downgraded from Buy to Hold on, Thursday, November 9th, 2023


This is the rating of the analyst that currently disagrees with Gregory


  • Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $9 on, Tuesday, February 20th, 2024
Contributing Sources